| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |